Coming soon to Soundful Silence Hearing!
A take home treatment device proven to reduce the symptoms of tinnitus
Lenire is a treatment device proven in large-scale clinical trials to reduce the symptoms of
tinnitus. It is designed to be used in the comfort of your own home with the support of a trained Lenire provider.
Lenire uses bimodal neuromodulation, a combination of soothing sound and gentle electrical stimulation to the tongue, to retrain your brain to pay less attention to your tinnitus sound. While Lenire is not a cure for tinnitus, it has been shown to significantly reduce the impact of tinnitus on day to day life.
​
​​
What does the research say?
Lenire has been proven to be a safe and effective treatment for tinnitus in three large-scale
clinical trials, and with real world patients.
ï‚· Trial 1 (TENT-A1): 80% of Lenire’s first clinical trial patients had a reduction in
tinnitus severity (as measured by the tinnitus handicap inventory (THI) that sustained for at least 12-months after treatment.
ï‚· Trial 2 (TENT-A2): 91% of Lenire’s second clinical trial patients had a reduction in
tinnitus severity (as measured by the THI) that sustained for at least 12-months after treatment.
ï‚· Trial 3 (TENT-A3): 70.5% of patients with moderate or worse tinnitus had significant
relief using Lenire when sound-only had no meaningful impact.
Following the success of TENT-A3, Lenire was awarded a De Novo FDA Approval grant by
the US FDA, creating a new category for tinnitus care with bimodal neuromodulation.
Analysis of 220 tinnitus patients treated with Lenire in Alaska Hearing & Tinnitus Center
further demonstrated Lenire’s effectiveness in the real world. The results of this analysis,
which were published in Nature Communications Medicine, showed that 91.5% of patients
had a clinically meaningful reduction in tinnitus handicap after just 12-weeks of Lenire.
References
1. TENT-A1: Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)
2. TENT-A2: Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized
trial, Sci Rep.
3. TENT-A3: Boedts, M., Beuchner, A., Khoo, S.G. et al Combining sound with tongue stimulation for the treatment of
tinnitus: a multi-site single-arm controlled pivotal trial. Nature communications (2024)
4. McMahan, E.E., Lim, H.H. Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for
tinnitus treatment in a clinical setting. Commun Med 5, 112 (2025). Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting | Communications Medicine
​
​
​
​
What is the device?
Bluetooth headphones
These are provided with the device and deliver customised sounds to activate the auditory nerve to the brain.
​
Tonguetip
The Tonguetip, specifically designed to treat tinnitus, sits comfortably in the closed mouth. Tiny electrodes on the Tonguetip deliver mild and safe energy pulses to the surface of the tip
of the tongue.
​
Controller
A lightweight handheld device that controls the timing and intensity of the treatment. You can start, pause and resume the treatment session, adjust the volume of the sound, and adjust
the level of the tongue stimulation.
​
The settings are fully customised by us to suit your tinnitus and hearing levels.
How does it work?
How do I get Lenire?
​​
Lenire is only available through trained healthcare partners and Soundful Silence Hearing is happy to announce that we will be adding it to our treatment options as of July 2025!
​​
All our tinnitus clients are required to attend an initial assessment consultation (£180) where we will perform a thorough hearing assessment, including ear examination and middle ear function tests (if indicated), gain a history of your tinnitus nature, onset and impact and also discuss any other symptoms such as hearing difficulties, dizziness or sound sensitivity. You will be asked to complete a tinnitus impact questionnaire and measures to assess for any associated or underlying anxiety or mood disorders which may be contributing to your tinnitus awareness. We will also discuss any contraindications for Lenire.
Once we have a thorough understanding of your tinnitus experience, all treatment options will be discussed and an individualised management plan created which is tailored to you. If Lenire is the treatment plan of choice you will be invited back for a fitting appointment where your device will be calibrated to your hearing and tongue sensitivity. You will receive thorough instruction on how to use the device and have time to practice in clinic. Treatment plans involve using the device for 1 hour a day for a minimum of 12 weeks. This generally consists of two 30 minute sessions at roughly the same times every day. You will then be followed up either in clinic or virtually via Teams at around 6-8 and 12-16 weeks. ​
​
The cost of a Lenire treatment package is £3595 including the device, fitting appointment and two follow ups. However we are running an introductory offer of £3295 for any clients who sign up for Lenire before the end of July 2025!
​
Additional bolt ons such as CBT based treatment plans, hearing aids and tinnitus retraining devices are also available at additional cost.
​
Contact us today to book your assessment slot
​
​
​
​
